Profile

Mr. James E.
Cecil
is a Managing Director at Valence Life Sciences LLC.
He is on the Board of Directors at Cardiocore Lab, Inc. Prior to joining Valence Life Sciences in 2012, Mr. Cecil was a Managing Director at Caxton Advantage Venture Partners.
Prior to joining the Fund, he was a Vice President in the Life Sciences Investment Banking Group at Piper Jaffray.
Before Piper Jaffray, he worked within the Health Care Investment Banking Group at Montgomery Securities.
He is currently a Board Observer at Caxton Advantage portfolio company, Regado Biosciences.
Mr. Cecil earned an MBA from The Wharton School, University of Pennsylvania and an MS in Biotechnology from the University of Pennsylvania with a concentration in Immunology.
He graduated Phi Beta Kappa from Lehigh University with a degree in Economics.

Former positions of Jay Cecil

CompaniesPositionEnd
Private Equity Investor 01/01/2012
Corporate Officer/Principal -
Montgomery Securities, Inc. Analyst-Equity -
Private Equity Investor -
Director/Board Member -
See the detail of Jay Cecil's experience

Training of Jay Cecil

University of Pennsylvania Graduate Degree
Lehigh University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jay Cecil's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies5

Health Services

Montgomery Securities, Inc.

Finance

Finance

Finance

Finance

See company connections